Treating Measles Infection: Nanoviricides CEO Dr Anil Diwan Interviewed by Steve Darling from Proactive
SHELTON, CONNECTICUT / ACCESS Newswire / October 29, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the "Company"),...
SHELTON, CONNECTICUT / ACCESS Newswire / October 29, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the "Company"),...
Setting a New Standard for Facial Rejuvenation and Aesthetic Expertise NEW YORK CITY, NY / ACCESS Newswire / October 29,...
Gorlin Syndrome, also known as Nevoid Basal Cell Carcinoma Syndrome, is a rare inherited genetic disorder affecting 1 in 31,000...
NORTHAMPTON, MA / ACCESS Newswire / October 29, 2025 / Bristol-Myers Squibb Company - Recently, the Innovative Cancer Medicines (ICM)...
PHOENIX, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc., (Nasdaq: CELZ) (the “Company”), a clinical-stage biotechnology company...
LITS Board of Directors Reaffirms Commitment to Driving Long-Term Stockholder ValueSAN DIEGO, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Lite Strategy,...
Zarminali Pediatrics releases data emphasizing the need for more connected, coordinated careCHICAGO, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Zarminali Pediatrics,...
New integration connects Vivian, the largest healthcare talent marketplace, with Hallmark’s Workforce Intelligence and Enablement Platform—streamlining travel nurse and allied...
NEWTOWN, Pa., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Solana Company (NASDAQ: HSDT) (the “Company” or “HSDT”) today announced its updated...
New corporate brand reflects strategic transformation to a global biotech platform accelerating access to innovative medicines for patients worldwideStrategy centers...
The partnership enables UnitedHealthcare to integrate telehealth nutrition services across Commercial and Medicare plans to enhance patient wellnessASHEVILLE, N.C., Oct....
Company aims to shorten time frame to make PDS0101 available to patients with HPV16-positive head and neck cancer, projected to...
HOUSTON, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company...
Secured Category III CPT Codes Pave the Way for Broader Access to Regenerative Skin ConstructSALT LAKE CITY, Oct. 29, 2025...
Peer-Reviewed Study Conducted in Collaboration with Mayo Clinic Demonstrates 100% Sensitivity and Strong Predictive Power for Esophageal Cancer Progression Early...
PETACH TIKVA, Israel, Oct. 29, 2025 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) ("PolyPid" or the "Company"), a late-stage biopharma company...
Kennewick, WA, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL) today announced enhanced cooperation with Exubrion Therapeutics to...
SEATTLE and VANCOUVER, British Columbia, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty...
MELBOURNE, Australia and PALM BEACH, Fla., Oct. 29, 2025 (GLOBE NEWSWIRE) -- CYIOS Corporation LLC (OTC: CYIO) (“CYIOS” or the...
The Harbinger Report Outlines The Firm's Independent Estimates For Significant Revenue Growth In The Coming Years Harbinger Research Initiates Coverage,...